Get the tools used by (smart)2 investors.

Inozyme Pharma IncNASDAQGS:INZY

United States / Healthcare / Biotechnology

Join now and get access to the full platform

Exchange Data

Hide this widget
1.00 USD
Price
-0.08 (-7.41%)
Day change
0.98 - 7.79
52-week range

Summary of Inozyme Pharma Inc

Hide this widget

Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculatu...

Dec 31, 2024
Latest Report
May 13, 2025
Next Earnings
Filings

Price History

Chart Gallery
Hide this widget
Loading chart...

Data Explorer

Hide this widget

Peer Benchmarks

Hide this widget
  INZY Peers Sector
Market Cap
64.221 M343.5 M64.23 M
Price % of 52 Week High
12.8%54.4%61.6%
Dividend Yield
0.0%0.0%0.0%
Shareholder Yield
-16.8%-9.3%-0.6%
1 Year Price Total Return
-82.2%-12.7%-11.6%
Beta (5 Year)
1.311.320.64

In the News

Finbox Fair Value

Hide this widget
What is Finbox Fair Value?
A stock's fair value is its real or underlying intrinsic worth.
Read more about Finbox's Fair Value methodology.
USD
Average
Upside
Uncertainty
You need an account to use this feature
Sign Up
Or
Log In

Financial Health

Financial Models for Inozyme Pharma Inc

Model Gallery
Hide this widget

Historical Financials

Full Financials
Hide this widget
(presentment in thousands)Trailing Twelve MonthsFiscal Quarters
Period EndingDec-22Dec-23Dec-24Dec-23Dec-24
Income Statement
Revenue
Operating Income(0.07)(0.08)(0.10)(0.02)(0.03)
Net Profit(0.07)(0.07)(0.10)(0.02)(0.03)
Diluted EPS-1.78-1.37-1.62-0.35-0.42
EBITDA(0.07)(0.07)(0.10)(0.02)(0.03)
Balance Sheet
Cash & ST Invest.0.130.190.110.190.11
Current Assets0.130.200.120.200.12
Total Assets0.140.200.120.200.12
Current Liabilities0.010.010.030.010.03
Total Liabilities0.020.060.070.060.07
Total Equity0.120.140.060.140.06
Total Debt0.010.050.050.050.05
Cash Flow Statement
Cash Flow Operations(0.06)(0.07)(0.09)(0.02)(0.02)
Cash From Investing(0.01)(0.05)0.07(0.01)0.02
Cash From Financing0.070.130.010.010.00
Free Cash Flow(0.06)(0.07)(0.09)(0.02)(0.02)

Analyst Notes

March 14, 2025
Hide this widget
    All rights reserved. Terms Of Use